CN1535314A - 同源性犬埃里希体28千道尔顿免疫优势蛋白质基因及其用途 - Google Patents

同源性犬埃里希体28千道尔顿免疫优势蛋白质基因及其用途 Download PDF

Info

Publication number
CN1535314A
CN1535314A CNA998137820A CN99813782A CN1535314A CN 1535314 A CN1535314 A CN 1535314A CN A998137820 A CNA998137820 A CN A998137820A CN 99813782 A CN99813782 A CN 99813782A CN 1535314 A CN1535314 A CN 1535314A
Authority
CN
China
Prior art keywords
ser
gly
seq
ile
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA998137820A
Other languages
English (en)
Chinese (zh)
Inventor
D��H���ֿ�
D·H·沃克
于学杰
J·W·麦克布里奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RESEARCH DEVELOPMENT FOUDATION
Original Assignee
RESEARCH DEVELOPMENT FOUDATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/201,458 external-priority patent/US6458942B1/en
Application filed by RESEARCH DEVELOPMENT FOUDATION filed Critical RESEARCH DEVELOPMENT FOUDATION
Publication of CN1535314A publication Critical patent/CN1535314A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CNA998137820A 1998-11-30 1999-11-24 同源性犬埃里希体28千道尔顿免疫优势蛋白质基因及其用途 Pending CN1535314A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/201,458 1998-11-30
US09/201,458 US6458942B1 (en) 1998-11-30 1998-11-30 28-kDa immunoreactive protein gene of Ehrlichia canis and uses thereof
US09/261,358 1999-03-03
US09/261,358 US6403780B1 (en) 1998-11-30 1999-03-03 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof

Publications (1)

Publication Number Publication Date
CN1535314A true CN1535314A (zh) 2004-10-06

Family

ID=26896771

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA998137820A Pending CN1535314A (zh) 1998-11-30 1999-11-24 同源性犬埃里希体28千道尔顿免疫优势蛋白质基因及其用途

Country Status (11)

Country Link
EP (1) EP1470223A4 (fr)
JP (1) JP2003527073A (fr)
CN (1) CN1535314A (fr)
AU (1) AU762315B2 (fr)
BR (1) BR9916141A (fr)
CA (1) CA2352466A1 (fr)
IL (1) IL143415A0 (fr)
NZ (1) NZ511922A (fr)
RU (1) RU2237716C2 (fr)
TW (1) TWI221481B (fr)
WO (1) WO2000032745A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888491B2 (en) 1998-09-18 2011-02-15 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6544517B1 (en) 1998-09-18 2003-04-08 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6392023B1 (en) 1999-03-03 2002-05-21 Research Development Foundation Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
US7335754B2 (en) 1999-07-21 2008-02-26 Cornell Research Foundation, Inc. Ehrlichia canis genes and vaccines
AU2001259304A1 (en) 2000-05-01 2001-11-12 Research Development Foundation Ehrlichia chaffeensis 28 kda outer membrane protein multigene family
US6432649B1 (en) * 2000-08-25 2002-08-13 The Ohio State University Research Foundation Methods for detecting Ehrlichia canis and Ehrlichia chaffeensis in vertebrate and invertebrate hosts
WO2008137881A2 (fr) 2007-05-04 2008-11-13 The Ohio State University Research Foundation Protéines d'ehrlichia ewingii, acides nucléiques, et procédés pour leur utilisation
US20140162256A1 (en) 2011-03-31 2014-06-12 Yasuko Rikihisa Compositions and methods for the detection of anaplasma platys
US9651546B2 (en) 2012-10-11 2017-05-16 Abaxis, Inc. Peptides, devices, and methods for the detection of ehrlichia antibodies
US9442112B2 (en) * 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025338A (en) * 1996-10-17 2000-02-15 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
CA2304256C (fr) 1997-09-19 2014-12-09 Yasuko Rikihisa Proteine de membrane externe de ehrlichia canis et ehrlichia chaffeenis

Also Published As

Publication number Publication date
JP2003527073A (ja) 2003-09-16
EP1470223A4 (fr) 2005-04-06
CA2352466A1 (fr) 2000-06-08
WO2000032745A3 (fr) 2004-05-21
EP1470223A2 (fr) 2004-10-27
AU762315B2 (en) 2003-06-19
TWI221481B (en) 2004-10-01
AU1923400A (en) 2000-06-19
RU2237716C2 (ru) 2004-10-10
BR9916141A (pt) 2001-12-04
IL143415A0 (en) 2002-04-21
NZ511922A (en) 2003-10-31
WO2000032745A2 (fr) 2000-06-08

Similar Documents

Publication Publication Date Title
CN1281747C (zh) 犬埃里希体120－kda免疫优势抗原性蛋白和基因
CN1473166A (zh) 犬埃里希体的同源28kD免疫优势蛋白质基因及其用途
CN1155707C (zh) 鼠疫疫苗
CN1268745C (zh) B组链球菌抗原
CN1654657A (zh) 新颖的链球菌抗原
CN1934131A (zh) Hpv52 l1在酵母中的优化表达
CN1535314A (zh) 同源性犬埃里希体28千道尔顿免疫优势蛋白质基因及其用途
CN1166858A (zh) tagA基因以及检测消化性溃疡和胃癌易感性的方法
CN1198932C (zh) 肺炎链球菌抗原
CN1628249A (zh) 副结核分枝杆菌感染的诊断和疫苗
CN1735684A (zh) 用于犬和人埃利希病的免疫诊断的p153和p156抗原及其用途
CN1849334A (zh) 胞内劳森氏菌亚单位疫苗
CN1784424A (zh) 编码人癌胚抗原的合成基因及其用途
CN1158387C (zh) 编码l.infantum的四种蛋白质的抗原决定簇的嵌合基因
CN1629188A (zh) 日本血吸虫的特异性抗原及用途
CN1800398A (zh) 李属坏死环斑病毒外壳蛋白基因及其专用检测引物
CN1898385A (zh) 多毛结肠短螺旋体72kDa外膜蛋白及其诊断和治疗用途
CN1629189A (zh) 日本血吸虫的特异性抗原及用途
CN1545552A (zh) 基因和蛋白质及它们的用途
CN1902314A (zh) NcSAG4基因用于诊断和预防新孢子虫病和作为分析发病机理的标志的用途
CN1616663A (zh) O型口蹄疫病毒dna疫苗及其制备方法
CN1670197A (zh) 日本血吸虫精氨酸酶，其编码核酸及其应用
CN1272436C (zh) 一种口蹄疫双价多肽疫苗基因合成及高效表达方法
CN1490332A (zh) 重组人ia－2抗原的制备方法
CN1800210A (zh) 治疗感染性疾病和免疫系统疾病的化合物及其使用方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication